Mirum Pharmaceuticals News

Mirum Pharmaceuticals Analyst Ratings

BenzingaMay 10 11:42 ET

Positive Outlook for Mirum Pharmaceuticals With Buy Rating Amid Upcoming Catalysts and Robust Financials

TipRanksMay 10 01:29 ET

Mirum Pharmaceuticals Analyst Ratings

BenzingaMay 9 13:42 ET

Analysts Offer Insights on Healthcare Companies: ACADIA Pharmaceuticals (ACAD), Beam Therapeutics (BEAM) and Mirum Pharmaceuticals (MIRM)

TipRanksMay 9 08:30 ET

Mirum Pharmaceuticals Analyst Ratings

BenzingaMay 9 06:37 ET

Mirum Pharmaceuticals Analyst Ratings

BenzingaApr 17 07:12 ET

Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX), Natera (NTRA) and Mirum Pharmaceuticals (MIRM)

TipRanksApr 10 02:11 ET

Analysts Offer Insights on Healthcare Companies: Mirum Pharmaceuticals (MIRM) and Rocket Pharmaceuticals (RCKT)

TipRanksApr 2 11:50 ET

Mirum Pharmaceuticals Analyst Ratings

BenzingaApr 2 11:36 ET

Mirum Pharmaceuticals Analyst Ratings

BenzingaMar 18 14:05 ET

Mirum Pharmaceuticals Analyst Ratings

BenzingaMar 14 06:43 ET

Buy Rating Affirmed for Mirum Pharmaceuticals Following FDA Approval and Positive Revenue Outlook

TipRanksMar 14 00:25 ET

Mirum Pharmaceuticals Analyst Ratings

BenzingaMar 4 10:25 ET

Buy Rating Affirmed for Mirum Pharmaceuticals Amid Strong Financials and Promising Regulatory Milestones

TipRanksMar 1 01:10 ET

Critical Insights From Mirum Pharmaceuticals Analyst Ratings: What You Need To Know

BenzingaFeb 29 14:02 ET

Cantor Fitzgerald Reiterates Overweight on Mirum Pharmaceuticals, Maintains $35 Price Target

BenzingaFeb 29 13:36 ET

Mirum Pharmaceuticals Analyst Ratings

BenzingaFeb 29 13:34 ET

Analysts Offer Insights on Healthcare Companies: Mirum Pharmaceuticals (MIRM) and Integra Lifesciences (IART)

TipRanksFeb 29 00:40 ET

Buy Rating Affirmed for Mirum Pharmaceuticals on Strong Sales and Growth Prospects

TipRanksFeb 27 06:26 ET

Mirum Pharmaceuticals' Strategic Acquisition Spurs Positive Market Projection and Maintains Buy Rating

TipRanksFeb 25 23:26 ET